about
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and ImmunotherapyTau Oligomers: The Toxic Player at Synapses in Alzheimer's DiseaseFrontotemporal lobar degeneration: old knowledge and new insight into the pathogenetic mechanisms of tau mutationsAmeliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast-Induced Traumatic Brain InjuryCo-expression of truncated and full-length tau induces severe neurotoxicityHumanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potencyCerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related Tauopathies.Characterization of tau oligomeric seeds in progressive supranuclear palsy.Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice.Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnosticsIsolation and characterization of antibody fragments selective for toxic oligomeric tauEctosomes: a new mechanism for non-exosomal secretion of tau protein.The role of tau in the pathological process and clinical expression of Huntington's diseaseA fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer's disease.Alzheimer's disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules."Tau oligomers," what we know and what we don't know.Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.Familial Alzheimer's disease modelling using induced pluripotent stem cell technology.Invited review: Drug development for tauopathies.Invited review: Animal models of tauopathies and their implications for research/translation into the clinic.The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration.Is Huntington's disease a tauopathy?Amyloid β-Exposed Human Astrocytes Overproduce Phospho-Tau and Overrelease It within Exosomes, Effects Suppressed by Calcilytic NPS 2143-Further Implications for Alzheimer's TherapyMultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice.Signaling pathways and posttranslational modifications of tau in Alzheimer's disease: the humanization of yeast cells.Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies.Do astrocytes collaborate with neurons in spreading the "infectious" aβ and Tau drivers of Alzheimer's disease?Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases.Tau imaging in progressive supranuclear palsy.Tau Oligomers Derived from Traumatic Brain Injury Cause Cognitive Impairment and Accelerate Onset of Pathology in Htau Mice.Neuronal Expression of Truncated Tau Efficiently Promotes Neurodegeneration in Animal Models: Pitfalls of Toxic Oligomer Analysis.
P2860
Q26747107-457B795E-2A07-4AF2-8F74-548C4A1022E1Q26773154-639997D1-C64B-4C20-8005-90E194F8C7C0Q26777247-CFBA9762-1A1B-4B08-A6C3-C53CECC9DCEFQ30387426-7574FE93-AB48-4664-A10A-56A4ABB1EC5EQ30829185-759A6320-3DAA-415C-99CD-4408BFA6E6E2Q33640390-57C61F40-06F9-4BE1-A4FE-229DC138340CQ33714234-B05EB004-E3B7-4AAB-9A20-454109F6E979Q34500234-F35D376C-4C6B-437B-9215-469556B4B020Q34794030-9183088A-65E5-4D12-97B7-6FF38898F90FQ35080258-EB48FD8B-06FE-49AA-956B-F2D40713CD3CQ35137455-6A272DD5-F6F1-49EB-B013-AC4BD1804520Q35196319-DAC183E1-C213-40D0-A109-1125FD127419Q36066666-23875722-0C0D-4331-8EE7-9458C98815A1Q36240389-93E17A50-B3B6-408B-ADB6-A4987448D987Q37057272-4A4C7D34-3F76-45FC-A43D-7F40B4736E0DQ37467443-78F549EF-E4DF-40AB-B935-0AA939FCB94BQ37736091-51253FAB-FF3B-47AC-A024-7D2597619567Q38207606-2A5F96BC-AA41-4CE8-99AE-3FC1EE2C900CQ38263698-38B39A47-EE97-4DEE-9607-FDF51118E896Q38271896-FA585787-6711-4BA1-ACD8-D9C92FE25051Q38520167-AD7909FA-FCD5-4DA5-BBB7-3F5B465BBE6CQ38771048-91E2460D-D855-4CF6-A0FB-FE3C661005C7Q38803172-19F2F984-3257-4434-974B-DC74E46CF190Q38892738-51651C30-582E-4328-9BB3-744D7AB3AB3CQ39208164-A900FD3E-5B23-4486-9EFB-96B0F1A4E3ECQ41760966-A1FACFF4-EC0B-43FD-9F80-4E3EE5E7798AQ42218999-8ED0DD08-C0CD-4227-BDF1-021534BCDEB3Q42355513-0121FCD3-6D78-4F89-8E8D-790320A482ACQ48424734-C4A90254-EB1E-4479-9D84-D1A79CA9568BQ49052601-B2D0422A-AFC2-41ED-ACF1-96871ACF9D4DQ50990954-9800A511-E4B2-460C-B8BE-F8D49CE5A586
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Formation and propagation of tau oligomeric seeds.
@en
type
label
Formation and propagation of tau oligomeric seeds.
@en
prefLabel
Formation and propagation of tau oligomeric seeds.
@en
P2860
P356
P1476
Formation and propagation of tau oligomeric seeds.
@en
P2093
Julia E Gerson
Rakez Kayed
P2860
P356
10.3389/FNEUR.2013.00093
P577
2013-07-17T00:00:00Z